home / stock / celuw / celuw quote
Last: | $0.0246 |
---|---|
Change Percent: | 3.66% |
Open: | $0.0237 |
Close: | $0.0246 |
High: | $0.0246 |
Low: | $0.0234 |
Volume: | 1,666 |
Last Trade Date Time: | 05/14/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0246 | $0.0237 | $0.0246 | $0.0246 | $0.0234 | 1,666 | 05-14-2024 |
$0.021249 | $0.0201 | $0.021249 | $0.0245 | $0.0124 | 3,600 | 05-13-2024 |
$0.028599 | $0.0298 | $0.028599 | $0.039 | $0.0175 | 8,724 | 05-10-2024 |
$0.02792 | $0.02 | $0.02792 | $0.02792 | $0.02 | 340 | 05-08-2024 |
$0.0259 | $0.02 | $0.0259 | $0.0267 | $0.02 | 2,200 | 05-07-2024 |
$0.03 | $0.0202 | $0.03 | $0.03 | $0.012 | 27,900 | 05-01-2024 |
$0.035 | $0 | $0.035 | $0 | $0 | 1 | 04-30-2024 |
$0.035 | $0.035 | $0.035 | $0.035 | $0.035 | 140 | 04-29-2024 |
$0.0255 | $0.0367 | $0.0255 | $0.0367 | $0.0255 | 1,001 | 04-25-2024 |
$0.0246 | $0.0374 | $0.0246 | $0.04 | $0.0246 | 60,200 | 04-24-2024 |
$0.035 | $0.0202 | $0.035 | $0.0393 | $0.0162 | 15,700 | 04-22-2024 |
$0.0396 | $0.0262 | $0.0396 | $0.0396 | $0.015 | 7,500 | 04-19-2024 |
$0.033999 | $0.033499 | $0.033999 | $0.033999 | $0.0271 | 300 | 04-17-2024 |
$0.0319 | $0.0353 | $0.0319 | $0.0353 | $0.03 | 5,073 | 04-16-2024 |
$0.0445 | $0.0343 | $0.0445 | $0.0489 | $0.03021 | 11,400 | 04-15-2024 |
$0.048 | $0.04 | $0.048 | $0.0493 | $0.0321 | 6,903 | 04-12-2024 |
$0.0498 | $0.041 | $0.0498 | $0.0498 | $0.041 | 400 | 04-11-2024 |
$0.040735 | $0.041216 | $0.040735 | $0.041216 | $0.04 | 5,333 | 04-10-2024 |
$0.0496 | $0.0474 | $0.0496 | $0.0497 | $0.045 | 2,235 | 04-05-2024 |
$0.04 | $0.0493 | $0.04 | $0.0493 | $0.04 | 2,200 | 04-04-2024 |
News, Short Squeeze, Breakout and More Instantly...
Celularity Inc. Warrant Company Name:
CELUW Stock Symbol:
NASDAQ Market:
FLORHAM PARK, N.J., May 14, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ: CELU) (“Celularity”), a regenerative and cellular medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial products, announced today that the Journa...
FLORHAM PARK, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ: CELU) (“Celularity”), a regenerative and cellular medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial products, announced today it will host ...
FLORHAM PARK, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ: CELU) (the “Company”), a regenerative medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial products, announced today that on April 17, 2024, the C...